Table 1.
Overview of the six service evaluation studies, including the demographic characteristics of the study populations
Study 1 | Study 2 | Study 3 | Study 4 | Study 5 | Study 6 | Total | ||
---|---|---|---|---|---|---|---|---|
Product | MW951S Sigma Virocult Kit |
Medline MD202003 dry swab with vial of 0.85% saline |
PROVIR Viral Transport Kit (TS/5–34 A) |
E&O BM1673- M043-3 Vial + Medium, Alphalab SW1040 |
Combination kit with ISS PBT093 tube filled with 3 ml TF saline and Citotest 2122-0008 swab |
BD Improve Medical Instruments 8,110,111 vial, 550,040 A dry swab |
. | |
Inclusion criteria | ≥ 18 years old; read and understood self-swabbing instructions | ≥ 18 years old; read and understood self-swabbing instructions | ≥ 18 years old; read and understood self-swabbing instructions | ≥ 18 years old; read and understood self-swabbing instructions | ≥ 18 years old; read and understood self-swabbing instructions | ≥ 18 years old; read and understood self-swabbing instructions | . | |
Location/site | Chessington Regional Test Centre and UK Biocentre | Manchester Airport | Leicester (Birstall Park & Ride) | Leicester (Birstall Park & Ride) | Leicester (Birstall Park & Ride) | Leicester (Birstall Park & Ride) | . | |
N (recruited) | 97 | 395 | 689 | 492 | 1,005 | 575 | 3,253 | |
N (with PCR outcome) | 90 | 348 | 654 | 458 | 892 | 491 | 2,933 | |
Median age (years); (min–max) | 43(19–67) | 40(18–81) | 37(18–84) | 36(18–81) | 38(18–81) | 35(18–84) | 37(18–84) | |
Sex: male (n,%) | 4 (4) | 113 (33) | 286 (44) | 212 (47) | 447 (50) | 239 (49) | 1,301 (44) | |
Sex: female (n,%) | 9 (10) | 117 (34) | 362 (55) | 243 (54) | 445 (50) | 252 (51) | 1,428 (49) | |
Sex: missing (n,%) | 77 (86) | 118 (34) | 6 (1) | 3 (1) | 0 | 0 | 204 (7) | |
Previous swabbing experience (%) | 39 | 20 | 23 | 20 | 56 | n/a | 29 |
The original study names were: Study 1: SE-SWTC1/SSES; Study 2: SE-SWTC3/COMBI006; Study 3: TS5-34 A; Study 4: COMBI021; Study 5: COMBI031; and Study 6: COMBI045. PCR, polymerase chain reaction